Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12595175 | 1.00 | ALDH1A1 (0.47) | ALDH1A1TSHRHSD17B10THRBMEN1 | |
| SCHEMBL11970056 | 1.00 | ALDH1A1 (0.47) | ALDH1A1TSHRHSD17B10THRBMEN1 | |
| SCHEMBL16329751 | 1.00 | ALDH1A1 (0.47) | ALDH1A1TSHRHSD17B10THRBMEN1 | |
| SCHEMBL11970063 | 1.00 | ALDH1A1 (0.47) | ALDH1A1TSHRHSD17B10THRBMEN1 | |
| SCHEMBL11969928 | 1.00 | ALDH1A1 (0.47) | ALDH1A1TSHRHSD17B10THRBMEN1 | |
| SCHEMBL394975 | 1.00 | — | — | |
| SCHEMBL12680272 | 1.00 | ALDH1A1 (0.47) | ALDH1A1TSHRHSD17B10THRBMEN1 | |
| SCHEMBL273877 | 1.00 | ALDH1A1 (0.47) | ALDH1A1TSHRHSD17B10THRBMEN1 | |
| SCHEMBL2473861 | 0.96 | ALDH1A1 (0.50) | ALDH1A1TSHRHSD17B10THRBMEN1 | |
| Ether SCHEMBL25432425 | 0.93 | ALDH1A1 (0.47) | ALDH1A1TSHRHSD17B10THRBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118159595-A | Sealing film composition for sealing micro-cells of electro-optical devices | 伊英克公司 | 2024-06-07 | — | — | CN | claimed |
| US-12622901-B2 | Compounds for tau protein degradation | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2026-05-12 | — | — | US | disclosed |
| US-12597635-B2 | Electrochemical device | MURATA MANUFACTURING CO., LTD. (JP) | 2026-04-07 | — | — | US | disclosed |
| EP-4697403-A1 | NEGATIVE-ELECTRODE ENHANCEMENT FILM FOR SECONDARY BATTERY, AND SECONDARY BATTERY AND ELECTRIC APPARATUS | Zhejiang Shengxing Technology Co., Ltd (CN) | 2026-02-18 | — | — | EP | disclosed |
| EP-4697415-A1 | SECONDARY BATTERY AND ELECTRIC APPARATUS | Zhejiang Shengxing Technology Co., Ltd (CN) | 2026-02-18 | — | — | EP | disclosed |
| US-20250388587-A1 | TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE | CULLGEN SHANGHAI INC (CN) | 2025-12-25 | — | — | US | disclosed |
| US-20240400570-A1 | TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE | CULLGEN (SHANGHAI), INC. (CN) | 2024-12-05 | — | — | US | disclosed |
| US-12144864-B2 | Tubulysins and protein-tubulysin conjugates | REGENERON PHARMACEUTICALS, INC. (US) | 2024-11-19 | — | — | US | disclosed |
| CN-116891654-B | Inkjet ink composition and recording method | 精工爱普生株式会社 | 2024-11-08 | — | — | CN | disclosed |
| US-12134610-B2 | Somatostatin subtype-2 receptor (SST2R) targeted therapeutics and uses thereof | Crinetics Pharmaceuticals, Inc. (US) | 2024-11-05 | — | — | US | disclosed |
| US-20090134366-A1 | COLOR FILTER INK, COLOR FILTER INK SET, COLOR FILTER, IMAGE DISPLAY DEVICE, AND ELECTRONIC DEVICE | SEIKO EPSON CORPORATION (JP) | 2009-05-28 | — | — | US | disclosed |
| US-20090130404-A1 | METHOD OF MANUFACTURING COLOR FILTER, COLOR FILTER, IMAGE DISPLAY DEVICE AND ELECTRONIC APPARATUS | SEIKO EPSON CORPORATION (JP) | 2009-05-21 | — | — | US | disclosed |
| US-20090128937-A1 | METHOD OF MANUFACTURING COLOR FILTER, COLOR FILTER, IMAGE DISPLAY DEVICE AND ELECTRONIC APPARATUS | SEIKO EPSON CORPORATION (JP) | 2009-05-21 | — | — | US | disclosed |
| US-20090128612-A1 | METHOD OF MANUFACTURING COLOR FILTER, COLOR FILTER, IMAGE DISPLAY DEVICE AND ELECTRONIC APPARATUS | SEIKO EPSON CORPORATION (JP) | 2009-05-21 | — | — | US | disclosed |
| CN-101393292-A | Color filter ink, color filter, image display device, and electronic device | SEIKO EPSON CORP (JP) | 2009-03-25 | — | — | CN | disclosed |
| CN-101393291-A | Color filter ink, color filter, image display device, and electronic device | SEIKO EPSON CORP (JP) | 2009-03-25 | — | — | CN | disclosed |
| US-20090073356-A1 | COLOR FILTER INK, COLOR FILTER, IMAGE DISPLAY DEVICE, AND ELECTRONIC DEVICE | SEIKO EPSON CORPORATION (JP) | 2009-03-19 | — | — | US | disclosed |
| US-20090073355-A1 | COLOR FILTER INK, COLOR FILTER, IMAGE DISPLAY DEVICE, AND ELECTRONIC DEVICE | SEIKO EPSON CORPORATION (JP) | 2009-03-19 | — | — | US | disclosed |
| US-20090015765-A1 | INK FOR USE IN A COLOR FILTER, COLOR FILTER, METHOD OF MANUFACTURING A COLOR FILTER, IMAGE DISPLAY APPARATUS, ELECTRONIC APPARATUS | SEIKO EPSON CORPORATION (JP) | 2009-01-15 | — | — | US | disclosed |
| CN-101344606-A | Ink for use in a color filter, color filter, method of manufacturing a color filter, image display apparatus, electronic apparatus | SEIKO EPSON CORP (JP) | 2009-01-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12134610-B2 | Somatostatin subtype-2 receptor (SST2R) targeted therapeutics and uses thereof | SSTR2, SSTR1, SSTR4 | ALDH1A1 4259/4885TSHR 25/4885HSD17B10 3261/4885 |
| US-20250388587-A1 | TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE | ERBB2, MUSK, ERBB3 | ALDH1A1 4483/4885TSHR 29/4885HSD17B10 3419/4885 |
| US-20240400570-A1 | TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE | MUSK, ERBB2, NTRK1 | ALDH1A1 4113/4885TSHR 652/4885HSD17B10 3640/4885 |
| US-12622901-B2 | Compounds for tau protein degradation | MAPT, UBQLN1, PSEN1 | ALDH1A1 4060/4885TSHR 2628/4885HSD17B10 4019/4885 |
| US-12597635-B2 | Electrochemical device | CLCN2, HCN4, SLC26A3 | ALDH1A1 2350/4885TSHR 1300/4885HSD17B10 2045/4885 |
| US-12144864-B2 | Tubulysins and protein-tubulysin conjugates | SDCBP, TEK, TEKT1 | ALDH1A1 4687/4885TSHR 2767/4885HSD17B10 3611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.